t-PA use in pediatric patients

J Pediatr Hematol Oncol. 2003 Jul;25(7):589; author reply 589. doi: 10.1097/00043426-200307000-00021.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Catheterization, Central Venous / adverse effects
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Infant
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator